Cargando…
Blood Lipid Disorders in Post-Operative Craniopharyngioma Children and Adolescents and the Improvement with Recombinant Human Growth Hormone Replacement
CONTEXT: The high prevalence of hypothalamic obesity (HO) and dyslipidemia in individuals with craniopharyngioma (CP) following surgery is a cause for increasing concern. However, few studies have explored the lipid profile in pediatric CP patients, with inconsistent findings. In addition, the role...
Autores principales: | Du, Han-Ze, Chen, Kang, Zhang, Li-Yuan, Zhang, Yue-Lun, Wu, Dan-Ning, Guo, Xiao-Yuan, Duan, Lian, Wang, Lin-Jie, Yang, Hong-Bo, Chen, Shi, Pan, Hui, Zhu, Hui-Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559785/ https://www.ncbi.nlm.nih.gov/pubmed/37810571 http://dx.doi.org/10.2147/DMSO.S425399 |
Ejemplares similares
-
Safety and effectiveness of recombinant human growth hormone replacement in postoperative craniopharyngioma children
por: Zheng, Zhang-qian, et al.
Publicado: (2013) -
Metabolic Effects of Recombinant Human Growth Hormone Replacement Therapy on Juvenile Patients after Craniopharyngioma Resection
por: Li, Shuying, et al.
Publicado: (2022) -
LTBK-02. Safety of growth hormone replacement therapy in childhood craniopharyngioma
por: van Schaik, Jiska, et al.
Publicado: (2022) -
Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma
por: Miao, Yuqi, et al.
Publicado: (2023) -
SAT-461 Long-Term Effects of Growth Hormone Replacement Therapy in Childhood-Onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (Hit-Endo)
por: Boekhoff, Svenja, et al.
Publicado: (2019)